Author

Robert Snijder

Institutions: Astellas Pharma (Netherlands), Postnova Analytics (Germany)

Observed institutions: Astellas Pharma (Netherlands), Postnova Analytics (Germany)

OpenAlex ID: A5158181543

The conformation-selective PI3Kδ inhibitor roginolisib in patients with advanced or metastatic cancer, including metastatic uveal melanoma: first-in-human clinical trial

2026 · Anna Maria Di Giacomo, Matteo Simonelli, et al. · Nature Communications · 3

Treatment patterns among US patients with muscle-invasive bladder cancer (MIBC) undergoing radical cystectomy (RC) during 2021–2024: Retrospective cohort study using the IQVIA database.

2026 · Ronald C. Chen, Kimberly Donnowitz, et al. · JCO Oncology Practice

Works count: 2

Citation count: 3

H-index: 1

I10-index: